<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="343035">
  <stage>Registered</stage>
  <submitdate>27/06/2011</submitdate>
  <approvaldate>12/07/2011</approvaldate>
  <actrnumber>ACTRN12611000727943</actrnumber>
  <trial_identification>
    <studytitle>TAP Block Study - A Prospective, Double-blind Randomised Trial to Assess the Efficacy of Ultrasound Guided Transversus Abdominis Plane Blocks Using Ropivacaine in Patients Undergoing Laparoscopic Abdominal Surgery.</studytitle>
    <scientifictitle>A Prospective, Double-blind Randomised Trial to Assess the Efficacy of Ultrasound Guided Transversus Abdominis Plane (TAP) Blocks Using Ropivacaine in Patients Undergoing Laparoscopic Abdominal Surgery.</scientifictitle>
    <utrn />
    <trialacronym>Transversus Abdominis Plane (TAP) Block</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Post-operative pain</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>All patients enrolled in the study who are undergoing elective abdominal laparoscopic surgery.
Intervention Procedure: A is ultrasound (US)-Guided single dose injection of local anaesthetic agent Ropivacaine (injected between the muscle layers in the abdomen after general anaesthesia has begun), with dose based on patient weight. Subjects will also receive Patient-Controlled Analgesia with Morphine (1mg per dose with 5 minute lockout) or Fentanyl (10mcg per dose with 5 minute lockout) administered intravenously at the discretion of the anaesthetist. Subjects allocated to the control group will receive Patient-Controlled Analgesia only. In both treatment groups the Patient-Controlled Analgesia will be administered for up to 4 days post-surgery or until no longer required.</interventions>
    <comparator>Patient-Controlled Analgesia with Morphine (1mg per dose with 5 minute lockout) or Fentanyl (10mcg per dose with 5 minute lockout) administered intravenously, commencing whilst in recovery and continuing for up to 4 days after surgery.</comparator>
    <control>Active</control>
    <interventioncode>Other interventions</interventioncode>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>mg/kg of morphine equivalent used by patients post operatively.</outcome>
      <timepoint>from operation until discharge from hospital narcotic use will be reviewed by examing patient-controlled analgesia infusion pumps to examine doses given per hour.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Lung Function (spirometry), including forced vital capacity (FVC), Forced Expiratory Volume (FEV1) and Peak Expiratory Flow Rate (PEFR)</outcome>
      <timepoint>24, 48 and 72 hours postoperatively.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Pain score as measured by a Visual Analogue Scale (VAS) for pain at rest, deep breathing and coughing</outcome>
      <timepoint>24, 48 and 72 hours postoperatively</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>All patients undergoing elective laparoscopic abdominal surgery by the three participating surgeons</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-Refuse or are unable to give written informed consent to participate in the study, or
-receive an epidural anaesthetic or other loco-regional anaesthesia, or
-are under 18 years of age, or
-have severe renal impairment
-receive an operation that involved incisions outside the abdominal wall (such as abdomino-perineal resections) or
-have a known allergy or adverse drug reaction to local anaesthetic agents or morphine or fentanyl, or
have a history of arrhythmia or long QT syndrome associated with the drugs used in this trial</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed opaque envelopes</concealment>
    <sequence>Permuted block randomisation using a computer generated random number sequence</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2 />
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>7/06/2011</anticipatedstartdate>
    <actualstartdate>15/07/2011</actualstartdate>
    <anticipatedenddate />
    <actualenddate>18/12/2012</actualenddate>
    <samplesize>140</samplesize>
    <actualsamplesize>142</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>John Hunter Hospital</primarysponsorname>
    <primarysponsoraddress>Locked Bag 1
Hunter Region Mail Centre NSW 2310</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Newcastle Private Hospital</sponsorname>
      <sponsoraddress>Lookout Road
New lambton Heights NSW 2305</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study will investigate whether the TAP block procedure using the local anaesthetic agent Ropivacaine is effective at managing pain in the first 24 hours after laparoscopic abdominal surgery.</summary>
    <trialwebsite />
    <publication>ANZ J Surg. 2014 May;84 Suppl 1:1-222. doi: 10.1111/ans.12605.
Abstracts of the RACS Annual Scientific Congress and ANZCA Annual Scientific Meeting, Singapore, 5-9 May 2014.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Hunter New England Human Research Ethics Committee</ethicname>
      <ethicaddress>Locked Bag 1
New Lambton NSW 2305</ethicaddress>
      <ethicapprovaldate>25/05/2011</ethicapprovaldate>
      <hrec>11/04/20/3.04</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Stephen Smith</name>
      <address>Newcastle Private Consultation Suites
Suite G7
Lookout Road 
New Lambton Heights NSW 2305</address>
      <phone>+61 2 49563243</phone>
      <fax />
      <email>stephen.smith@hnehealth.nsw.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Rosemary Carroll</name>
      <address>Division of Surgery
John Hunter Hospital
Locked Bag 1
Hunter Region Mail Centre NSW 2310</address>
      <phone>+61 2 49855153</phone>
      <fax />
      <email>rosemary.carroll@hnehealth.nsw.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Rosemary Carroll</name>
      <address>A/A</address>
      <phone>+61 2 49855153</phone>
      <fax />
      <email>rosemary.carroll@hnehealth.nsw.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Stephen Smith</name>
      <address>Newcastle Private Consultation Suites 
Suite G7 
Lookout Road New Lambton Heights NSW 2305</address>
      <phone>+61 2 49563243</phone>
      <fax />
      <email>stephen.smith@hnehealth.nsw.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>